251
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Facile synthesis of some new functionalized 2-selenoxopyrimidines

, & ORCID Icon
Pages 324-330 | Received 26 Aug 2019, Accepted 13 Nov 2019, Published online: 23 Nov 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sadaf Saeed, Ameer Fawad Zahoor, Matloob Ahmad, Muhammad Naveed Anjum, Rabia Akhtar & Irum Shahzadi. (2022) Synthetic methodologies for the construction of selenium-containing heterocycles: a review. Phosphorus, Sulfur, and Silicon and the Related Elements 197:11, pages 1096-1122.
Read now
Behzad Mohammadi, Farahnaz K. Behbahani, Gholam B. Marandi & Behrouz Mirza. (2021) One-pot synthesis of 3,4-dihydropyrimidin-2(1H)-ones, thiones and 2-selenoxo DHPMs using 1-butyl-3-methylimidazolium hydrogen sulfate as non-halogenated ionic liquid. Phosphorus, Sulfur, and Silicon and the Related Elements 196:1, pages 54-60.
Read now

Articles from other publishers (4)

A.M. Abdelghany, A.M. Sarhan, E. Abdel-Latif & F.I. El-Dossoki. (2021) Synthesis and characterization of CuO/ZnO/Al2O3 particles and its utilization as a catalyst for acrylamide derivatives. Journal of Molecular Structure 1241, pages 130664.
Crossref
Priyanka N. Makhal, Arijit Nandi & Venkata Rao Kaki. (2021) Insights into the Recent Synthetic Advances of Organoselenium Compounds. ChemistrySelect 6:4, pages 663-679.
Crossref
Tarik E. Ali, Mohammed A. Assiri & Hanaa R. Aboelwafa. (2021) Synthesis and Cytotoxicity Properties of Some Novel Functionalized 2-{2-[(4-Oxo-4H-chromen-3-yl)methylene]hydrazinyl}-1,3-selenazoles. HETEROCYCLES 102:5, pages 920.
Crossref
Tarik E. Ali, Mohammed A. Assiri, Mamdouh M. Ali, Abeer E. M. Ali, Ibrahim S. Yahia & Heba. Y. Zahran. (2020) Efficient Synthesis and Anticancer Activities of Some Novel Functionalized (4-Oxo-4H-chromen-3-yl)-2-selenoxo-1,2-dihydropyrimidines. HETEROCYCLES 100:11, pages 1831.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.